Cura Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
2,066
-22
-1% -$12.3K 0.46% 32
2026
Q1
$1.17M Hold
2,088
0.53% 32
2025
Q4
$1.41M Sell
2,088
-993
-32% -$676K 0.54% 29
2025
Q3
$1.97M Sell
3,081
-784
-20% -$476K 0.75% 23
2025
Q2
$2.07M Sell
3,865
-4,251
-52% -$2.03M 0.83% 23
2025
Q1
$3.41M Buy
8,116
+77
+1% +$33.4K 1.38% 16
2024
Q4
$3.32M Buy
+8,039
New +$3.53M 1.47% 14

Other funds holding IDXX

Cura Wealth Advisors's IDXX Position: Q2 2026 in Review

Cura Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 1.1% in Q2 2026, selling an estimated $12.3K and leaving 2,066 shares worth $1.09M. The position accounts for 0.46% of the portfolio, ranked #32.

Cura Wealth Advisors first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.41M in Q1 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cura Wealth Advisors held 2,066 shares of Idexx Laboratories worth $1.09M as of Q2 2026.
  • Cura Wealth Advisors sold 22 Idexx Laboratories shares in Q2 2026, an estimated $12.3K.
  • Idexx Laboratories made up 0.46% of Cura Wealth Advisors's portfolio in Q2 2026, its #32 holding.
  • Cura Wealth Advisors first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Cura Wealth Advisors's Idexx Laboratories position peaked at $3.41M in Q1 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cura Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.